Positron emission tomography (PET) is a molecular imaging technique that can provide information on cellular functions in vivo. The PET imaging probe [18F]-FDG is used clinically to detect, stage, and monitor cancer. Life-threatening acute liver failure can be triggered by a variety of factors, including common drugs such as Tylenol. PET imaging is rarely used to monitor liver diseases, in part due to a lack of specific imaging agents for liver function. PET imaging of the liver could have an important impact on the diagnosis and treatment of such conditions as acute liver failure and hepatocellular carcinoma. Here we report a new PET imaging probe, 2-deoxy-2- 
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Scientific Abstract:
Life-threatening acute liver failure can be triggered by a variety of factors, including common drugs such as acetaminophen. Positron emission tomography (PET) is rarely used to monitor liver function, in part because of a lack of specific imaging agents for liver function. 
